Susquehanna International Group’s Navidea Biopharmaceuticals NAVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NAVB
WAM
Susquehanna International Group's NAVB Position: Q3 2023 in Review
Susquehanna International Group sold out of Navidea Biopharmaceuticals (NAVB) in Q3 2023, closing a stake of 125,866 shares — an estimated $11.6K sold.
Susquehanna International Group first reported a position in NAVB in Q2 2013 and held it in 25 quarters. The position peaked at $14.2M in Q3 2015. 24 funds tracked by Wall St. Rank hold NAVB as of Q3 2023.
- Susquehanna International Group reported no remaining Navidea Biopharmaceuticals position as of Q3 2023 after selling out during the quarter.
- Susquehanna International Group sold 125,866 Navidea Biopharmaceuticals shares in Q3 2023, an estimated $11.6K.
- Susquehanna International Group first reported a position in Navidea Biopharmaceuticals in Q2 2013 and held it in 25 quarters.
- Susquehanna International Group's Navidea Biopharmaceuticals position peaked at $14.2M in Q3 2015.
- 24 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals as of Q3 2023.
Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.